Neurocrine Biosciences (NBIX) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $152.74 -2.4%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
